oxybutynin has been researched along with Glaucoma, Angle Closure in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sung, VC | 1 |
| Corridan, PG | 1 |
2 other studies available for oxybutynin and Glaucoma, Angle Closure
| Article | Year |
|---|---|
Acute-angle closure glaucoma as a side-effect of oxybutynin.
Topics: Acute Disease; Aged; Aged, 80 and over; Cholinergic Antagonists; Female; Glaucoma, Angle-Closure; Hu | 1998 |
Clarification--Drug risk in patients with glaucoma.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Contraindications; Cresols; Glaucoma, Angle-Closure; | 2001 |